We are live on ! Find out more
MGNX icon

MacroGenics
MGNX

135 hedge funds and large institutions have $375M invested in MacroGenics in 2022 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 41 increasing their positions, 48 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

89% more capital invested

Capital invested by funds: $199M → $375M (+$176M)

4% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 27

0% more funds holding

Funds holding: 135 → 135 (0)

7% less call options, than puts

Call options by funds: $360K | Put options by funds: $388K

1.35% less ownership

Funds ownership: 93.58% → 92.23% (-1.3%)

15% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 48

Holders
135
Holders Change
–
Holders Change %
0%
% of All Funds
2.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
41
Reduced
48
Closed
27
Calls
$360K
Puts
$388K
Net Calls
-$28K
Net Calls Change
-$60K

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$9.07M
2
SCM
Silverarc Capital Management
Massachusetts
+$2.81M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.69M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.57M
5
BlackRock
BlackRock
New York
+$1.47M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.03M
2
WA
Wasatch Advisors
Utah
-$3.61M
3
FLSM
Frazier Life Sciences Management
California
-$2.43M
4
AQR Capital Management
AQR Capital Management
Connecticut
-$2.36M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$2.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Bellevue Group
Switzerland
$60.3M +$9.07M +1,654,399 +23%
AC
2
Armistice Capital
New York
$40.9M -$197K -36,000 -0.6%
BlackRock
3
BlackRock
New York
$40.2M +$1.47M +267,560 +5%
Vanguard Group
4
Vanguard Group
Pennsylvania
$29.8M +$1.44M +262,123 +6%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$19.3M -$29K -5,281 -0.2%
Millennium Management
6
Millennium Management
New York
$18.8M -$4.03M -734,717 -21%
WA
7
Wasatch Advisors
Utah
$15M -$3.61M -657,687 -23%
Assenagon Asset Management
8
Assenagon Asset Management
Luxembourg
$10M -$1.68M -305,746 -17%
State Street
9
State Street
Massachusetts
$8.67M -$471K -85,891 -6%
Two Sigma Advisers
10
Two Sigma Advisers
New York
$7.64M +$1.05M +191,500 +20%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$7.58M +$443K +80,830 +8%
RSCM
12
Rock Springs Capital Management
Maryland
$7.54M -$458K -83,546 -7%
EC
13
EcoR1 Capital
California
$7.5M +$1.02M +186,500 +20%
Acadian Asset Management
14
Acadian Asset Management
Massachusetts
$7.09M +$217K +39,607 +4%
Federated Hermes
15
Federated Hermes
Pennsylvania
$6.68M -$2.27M -414,617 -29%
BBA
16
Baker Bros. Advisors
New York
$5.99M – – –
Northern Trust
17
Northern Trust
Illinois
$4.85M -$233K -42,505 -6%
Two Sigma Investments
18
Two Sigma Investments
New York
$4.71M +$1.69M +307,660 +78%
Morgan Stanley
19
Morgan Stanley
New York
$4.34M -$725K -132,126 -17%
SCM
20
Silverarc Capital Management
Massachusetts
$4.11M +$2.81M +512,475 +512%
N
21
Nuveen
North Carolina
$3.47M +$110K +20,120 +4%
Goldman Sachs
22
Goldman Sachs
New York
$3.38M +$225K +41,031 +9%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$3.31M -$475K -86,626 -15%
Renaissance Technologies
24
Renaissance Technologies
New York
$3.24M -$143K -26,100 -5%
Citadel Advisors
25
Citadel Advisors
Florida
$3.07M -$43.8K -7,985 -2%
1
2 3 4 5

MGNX Hedge Fund Activity: Q4 2022 in Review

135 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2022, worth a combined $375M — up 89% from $199M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new MGNX positions and 27 closed out — a net gain of 1 holder — while 41 added to existing stakes and 48 trimmed.

The largest buyer was Bellevue Group, adding an estimated $9.07M. The largest seller was Millennium Management, cutting an estimated $4.03M.

  • 135 institutional investors held MacroGenics (MGNX) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $375M of MacroGenics stock for Q4 2022, up 89% quarter-over-quarter.
  • 28 funds opened new MacroGenics positions in Q4 2022 and 27 closed out, a net change of +1 holder.
  • The largest MacroGenics buyer in Q4 2022 was Bellevue Group, an estimated $9.07M added.
  • The largest MacroGenics seller in Q4 2022 was Millennium Management, an estimated $4.03M sold.

Based on aggregated 13F filings for Q4 2022.